Related Experiment Video
Updated: Jul 22, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
Pediatric adenovirus pneumonia: clinical practice and current treatment
Jie Zhang1, Yiting Zhu1, Yiyang Zhou1
1Department of Pediatrics, The Second School of Medicine, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Insights
Severe pediatric adenovirus pneumonia, a common respiratory infection, has high mortality and sequelae. Early recognition and management are crucial, as viral load impacts prognosis.
Area of Science:
- Pediatric Infectious Diseases
- Respiratory Medicine
- Virology
Background:
- Adenovirus pneumonia is a frequent pediatric upper respiratory tract infection with a high risk of severe outcomes and mortality.
- Adenoviruses cause direct cellular damage and trigger immune responses, complicating the infection.
- Current treatments lack specificity, necessitating supportive care and management of complications.
Purpose of the Study:
- To review the pathogenesis, early recognition, and therapeutic strategies for severe pediatric adenovirus pneumonia.
- To identify risk factors associated with poor outcomes, including post-infectious bronchiolitis obliterans (PIBO) and death.
- To highlight the significance of viral load and serological identification in assessing severity and prognosis.
Main Methods:
- Review of current literature on adenovirus pneumonia in children.
- Analysis of clinical symptoms, laboratory tests, and imaging findings for early recognition.
- Evaluation of treatment modalities including antiviral drugs, respiratory support, and immunomodulatory therapy.
- Identification of risk factors for severe disease, PIBO, and mortality.
Main Results:
- Early recognition involves specific symptoms (dyspnea, toxic symptoms), CT findings (atelectasis), and elevated inflammatory markers (CRP, PCT) in young children.
- Key complications include PIBO and hemophagocytic syndrome; risk factors for PIBO include mechanical ventilation, steroid use, fever duration, and male gender.
- Factors associated with mortality include hypoxemia, hypercapnia, mechanical ventilation, and low albumin levels.
- Viral load and serological identification are critical for diagnosis and prognosis.
Conclusions:
- Effective management of severe pediatric adenovirus pneumonia requires prompt recognition and supportive care.
- Identifying and mitigating risk factors for PIBO and mortality is essential for improving patient outcomes.
- Viral load serves as a crucial indicator for disease severity and prognosis in adenovirus pneumonia.
Abstract:
Adenovirus pneumonia is common in pediatric upper respiratory tract infection, which is comparatively easy to develop into severe cases and has a high mortality rate with many influential sequelae. As for pathogenesis, adenoviruses can directly damage target cells and activate the immune response to varying degrees. Early clinical recognition depends on patients' symptoms and laboratory tests, including those under 2 years old, dyspnea with systemic toxic symptoms, atelectasis or emphysema in CT image, decreased leukocytes, and significantly increased C-reaction protein (CRP) and procalcitonin (PCT), indicating the possibility of severe cases. Until now, there is no specific drug for adenovirus pneumonia, so in clinical practice, current treatment comprises antiviral drugs, respiratory support and bronchoscopy, immunomodulatory therapy, and blood purification. Additionally, post-infectious bronchiolitis obliterans (PIBO), hemophagocytic syndrome, and death should be carefully noted. Independent risk factors associated with the development of PIBO are invasive mechanical ventilation, intravenous steroid use, duration of fever, and male gender. Meanwhile, hypoxemia, hypercapnia, invasive mechanical ventilation, and low serum albumin levels are related to death. Among these, viral load and serological identification are not only "gold standard" for adenovirus pneumonia, but are also related to the severity and prognosis. Here, we discuss the progress of pathogenesis, early recognition, therapy, and risk factors for poor outcomes regarding severe pediatric adenovirus pneumonia.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology

